Inhibitor of apoptosis proteins (IAPs) are negative regulators of apoptosis. As IAPs are overexpressed in many tumors, where they confer chemoresistance, small molecules inactivating IAPs have been proposed as anticancer agents. Accordingly, a number of IAP-binding pro-apoptotic compounds that mimic the sequence corresponding to the N-terminal tetrapeptide of Smac/DIABLO, the natural endogenous IAPs inhibitor, have been developed. Here, we report the crystal structures of the BIR3 domain of cIAP1 in complex with Smac037, a Smac-mimetic known to bind potently to the XIAP-BIR3 domain and to induce degradation of cIAP1, and in complex with the novel Smac-mimetic compound Smac066. Thermal stability and fluorescence polarization assays show the stabilizing effect and the high affinity of both Smac037 and Smac066 for cIAP1- and cIAP2-BIR3 domains.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009409PMC
http://dx.doi.org/10.1002/pro.523DOI Listing

Publication Analysis

Top Keywords

domain ciap1
8
ciap1 complex
8
recognition smac-mimetic
4
smac-mimetic compounds
4
compounds bir
4
bir domain
4
ciap1 inhibitor
4
inhibitor apoptosis
4
apoptosis proteins
4
iaps
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!